Procter & Gamble (PG)
Procter & Gamble R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these PG related companies
PG News
Proctor & Gamble (PG) To Change 'Tide Pods' Design So Kids Don't Eat Them
May 25, 11:23AM Street Insider
May 25, 11:23AM Street Insider
$PG Mentioned more than normal on StockTwits - Currently at 3 x average daily social activity
about 2 days ago by TradeIdeasQuant
about 2 days ago by TradeIdeasQuant
These giant multinationals have the largest exposure to emerging markets $WYNN $KO $PEP $PG http://stks.co/3yk6
about 2 days ago by eyeonequities
about 2 days ago by eyeonequities
Thursday links: clearly better options | via @abnormalreturns http://stks.co/3yd8 $PG $HPQ $BX $GS
about 2 days ago by STNet
about 2 days ago by STNet
Thursday links: ETFs=DVDs, the return of all-or-nothing days and walking on the moon. http://stks.co/3ybY $SPX $VIX $PG $HPQ $BX $FB $GS
about 2 days ago by abnormalreturns
about 2 days ago by abnormalreturns
Oh and re: $HPQ CEO Whitman: She's old (55), rich (worth >$1B) & on boards of $ZIP $PG and Teach for America. Not exactly eyes on the prize.
about 2 days ago by JeffReevesIP
about 2 days ago by JeffReevesIP
May 24 Support/resistance numbers for S&P and top components. http://stks.co/3y4b $ES_F $AAPL $XOM $CVX $JNJ $PG $$
about 2 days ago by TripleDTrader
about 2 days ago by TripleDTrader
$PG is perfect proof that there is no guarantee to easy emerging markets magic. At the end of the day, you still have to executive.
about 2 days ago by bradloncar
about 2 days ago by bradloncar
More Bearish Signals Again Today: New $PG and $KLAC Bearish Positions Added To Portfolio! http://stks.co/3y1d $AIV $GT $HRL $SPY
about 3 days ago by elliottwave
about 3 days ago by elliottwave
Bob McDonald’s Quandary: Save the World or Maintain P&G’s Dividend, Yielding 3.5% http://stks.co/3xc5 $PG $K $DMND $TEVA
about 3 days ago by ycharts
about 3 days ago by ycharts
$PG not looking good. Can go from 63 to 53.. just in case Mr Buffet checks stocktwits
about 4 days ago by vjtweet
about 4 days ago by vjtweet
UBS Trims Estimates and PT on McDonald's (NYSE: MCD), However Stock Still Deserves Premium Valuation
May 18, 1:40PM Street Insider
May 18, 1:40PM Street Insider
Expectations Indicator triggered a Bear Market http://stks.co/3sKX $HD $PG $UTX $VZ
about 9 days ago by LouisEbner
about 9 days ago by LouisEbner
Jones Lang LaSalle (JLL) Announces Extension of Global Real Estate Alliance with P&G (PG)
May 15, 9:02AM Street Insider
May 15, 9:02AM Street Insider
Jones Lang LaSalle Extends Global Strategic Real Estate Alliance with Procter & Gamble
May 15, 9:01AM Benzinga
May 15, 9:01AM Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PG | 62.49 | -0.08 | -0.13% | 172.12B |
| PFS | 14.36 | +0.02 | +0.14% | 871.65M |
| PFE | 22.13 | -0.01 | -0.05% | 166.80B |
| PFBC | 12.04 | +0.10 | +0.84% | 158.81M |
| PFA | 14.80 | +0.11 | +0.75% | |
| PETS | 11.88 | +0.17 | +1.45% | 241.64M |
| PER | 19.66 | -0.29 | -1.45% | 774.21M |
| PEGA | 31.71 | -0.06 | -0.19% | 1.199B |
| PDP | 26.51 | -0.09 | -0.34% | |
| PDLI | 6.48 | -0.01 | -0.15% | 906.42M |
